Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Psych MEQs / SAQsAddiction psychiatry

Psych MEQs / SAQs · Addiction psychiatry

Alcohol use disorder — detox, Wernicke, and relapse prevention (MEQ)

FRANZCP-style MEQ on AUD nosology, CIWA-Ar, benzodiazepine detox, Caine/Wernicke thiamine, naltrexone/acamprosate/disulfiram, psychosocial package.

20 marks20 min1 min readVerification in progress

Target exams

FRANZCPMRCPsychABPNMD-DNB
On this page
Study tools

Target exams

FRANZCPMRCPsychABPNMD-DNB
Prompt
A 51-year-old man with twenty years of heavy daily drinking is admitted after a fall. Last drink was 18 hours ago. He is tremulous, sweaty, HR 118, BP 162/96, oriented to person but not time. AUDIT is high. He has poor nutrition, horizontal nystagmus, and a wide-based gait. He asks for 'something to stop the shakes' and says he will discharge against advice tonight to drink. (i) State DSM-5-TR severity logic if he meets seven criteria and contrast with ICD-11 dependence language. (ii) Outline immediate assessment including named withdrawal scale and risk domains. (iii) Manage acute withdrawal and suspected Wernicke with named drug doses/routes where standard teaching applies. (iv) Plan post-detox pharmacotherapy options with doses and key contraindications. (v) Address psychosocial care, dual diagnosis screening, and disposition. (20 marks)

Model answer

Reveal model answerShowHide

(i) Nosology. Seven DSM-5-TR criteria in twelve months = severe AUD (mild 2–3, moderate 4–5, severe ≥6). ICD-11 would likely frame alcohol dependence if impaired control, primacy of use, and persistence despite harm (with physiological features) are present — do not mix criterion counts with ICD labels carelessly.[6]

(ii) Assessment. ABCDE, glucose, trauma from fall, full alcohol/substance history (last drink time critical), MSE, suicide/violence/vulnerability risk, capacity regarding self-discharge, collateral. Score CIWA-Ar (ten items, max 67) to guide symptom-triggered benzodiazepines if assessable. Screen mood/psychosis/other substances (dual diagnosis). Labs: FBC, U and E, Mg/phosphate, LFTs, coags; imaging if head injury concern.[1][5][6]

(iii) Acute management. Admit — high risk (withdrawal already, fall, Wernicke features, AMA threat). Benzodiazepines first-line (e.g. diazepam or lorazepam 1–2 mg titrated if liver concern) symptom-triggered per CIWA-Ar protocol. Wernicke: Caine criteria met (malnutrition + oculomotor + cerebellar — any two suffice); give high-dose parenteral thiamine urgently (EFNS/RCP-style teaching often 500 mg IV TDS for days then step-down — follow local protocol); do not rely on oral thiamine alone; cover thiamine when giving glucose.[2][4][5] Supportive care, electrolytes, seizure precautions, continuous monitoring; escalate if evolving DT.

(iv) Relapse prevention (after stabilisation). Offer naltrexone 50 mg oral daily if opioid-free and LFTs acceptable; or acamprosate 666 mg TDS after detox if renal function allows; or supervised disulfiram 200–250 mg daily only with consent, education, and suitable candidate. State contraindications (naltrexone/opioids; acamprosate/severe renal failure; disulfiram/cardiac risk, unsupervised drinking).[3][7][8]

(v) Psychosocial and disposition. MET/CBT/mutual aid, social work for housing, safety planning for AMA risk, dual diagnosis follow-up, early outpatient addiction review, consider residential if community supports fail. Document capacity and least-restrictive options under jurisdiction-specific law without inventing foreign section numbers.[3][6]

Psychiatry Fellowship Pro

Continue reading

You have read the opening of this meqs / saq. The complete unit — every section and its primary-source references — is part of the Psychiatry Fellowship fellowship library.

Sign in to continueSee pricing
References8ShowHide
  1. [1]Sullivan JT, Sykora K, Schneiderman J, et al. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict, 1989.PMID 2597811
  2. [2]Caine D, Halliday GM, Kril JJ, et al. Operational criteria for the classification of chronic alcoholics: identification of Wernicke's encephalopathy. J Neurol Neurosurg Psychiatry, 1997.PMID 9010400
  3. [3]Reus VI, Fochtmann LJ, Bukstein O, et al. The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder. Am J Psychiatry, 2018.PMID 29301420
  4. [4]Galvin R, Bråthen G, Ivashynka A, et al. EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy. Eur J Neurol, 2010.PMID 20642790
  5. [5]Mayo-Smith MF Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. JAMA, 1997.PMID 9214531
  6. [6]Connor JP, Haber PS, Hall WD Alcohol use disorders. Lancet, 2016.PMID 26343838
  7. [7]Jonas DE, Amick HR, Feltner C, et al. Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis. JAMA, 2014.PMID 24825644
  8. [8]Fuller RK, Gordis E Does disulfiram have a role in alcoholism treatment today? Addiction, 2004.PMID 14678055
Psychiatry Fellowship Pro

$29/ monthor $279 / year

The complete Psychiatry Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousAddiction in older adults — late-onset alcohol and long-term benzodiazepine (MEQ)Addiction psychiatryNextAlcohol withdrawal and delirium tremens — CIWA, seizures, DT, thiamine (MEQ)Addiction psychiatry